Condition: Chronic Kidney Disease Requiring Chronic Dialysis · Vaccine Response · Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
The aim of this observational study is to determine if and how kidney failure affects the development of protective immune responses following vaccination in patients on chronic dialysis. Researchers will compare the effectiveness of the influenza vaccine in inducing protective antibodies between hemodialysis patients and subjects without chronic kidney disease. Participants will: * Be enrolled at the time of influenza vaccination * Visit the clinic at 7, 14, 30, 60, and 120 days after vaccination * Be asked to provide relevant clinical information and a blood sample at each visit
This description comes directly from the study's public registry record.
Manuel A Podesta', MD, PhD · 0039 0255034568 · manuel.podesta@policlinico.mi.it
Giuseppe Castellano, MD, PhD · giuseppe.castellano@policlinico.mi.it
Always discuss trial participation with your own doctor first.
| Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico | Milan, Italy | Recruiting |
| ASST Santi Paolo e Carlo | Milan, Italy | Not Yet Recruiting |
| ASST Fatebenefratelli Sacco | Milan, Italy | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06635525